PCSK9 Inhibitor Very Effective in High-risk Patients Without ASCVD: VESALIUS-CV
Investigators suggest LDL targets typically reserved for secondary prevention are best in high-risk patients with diabetes. NEW ORLEANS—Adding…
Browsing Tag